ACA exchange sign-ups outpacing last year

The number of enrollees in plans offered on health insurance exchanges has increased slightly compared to the last open enrollment period, with sign-ups accelerating before the deadline to get coverage starting Jan. 1, 2017.

According to the latest enrollment figures from HHS, more than four million people have selected a plan since open enrollment began on Nov. 1. In 2015, 3.75 million people had signed up in the same 40-day period.

“Momentum is building,” said HHS Secretary Sylvia Burwell. “Most Marketplace consumers can find plans for less than $75 per month in premiums, and it’s easier than ever to shop and compare your options on HealthCare.gov.”

The two biggest days of enrollment so far were Dec. 12 and 13, when more than 700,000 people signed up.

However, most of the enrollees are returning customers, not new ones. About 25 percent of the sign-ups are from first-time buyers on the exchange, compared to the 40 percent share of new customers last year.

The figures only reflect sign-ups on the federal Healthcare.gov website. Enrollment on the 11 state-based exchanges, along with the District of Columbia, is not included.

The largest state-based exchange, Covered California, reported increased demand from customers, with 1.2 million people renewing plans and another 153,000 first-timers buying coverage. The demand was great enough that the exchange extended its deadline for Jan. 1 coverage, giving customers until midnight on Dec. 17 to have a plan in place for the new year.

“This strong demand shows that Californians are using the competitive marketplace that Covered California provides,” said Peter V. Lee, executive director of Covered California. “We are ahead of last year’s pace and are giving our Service Center staff and certified enrollers the time they need to bring health care coverage to thousands more.”

Enrollment had increased just after the surprising presidential election victory by Donald Trump, who has vowed to repeal the Affordable Care Act. It will continue through the end of January, less than two weeks after Trump will have taken office. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.